#Contraceptives Market growth

[insightfulblogz]

Contraceptives Market Driving Factors, Investment Feasibility, and Analysis by 2032

The contraceptives market has become a pivotal part of healthcare, offering a variety of solutions for family planning and reproductive health. Contraceptive options include hormonal pills, intrauterine devices (IUDs), implants, injectables, and barrier methods, each catering to diverse user needs. The market's growth is fueled by increased awareness about reproductive health, the desire for effective birth control methods, and government initiatives promoting family planning. By providing accessible and reliable contraceptive solutions, this market plays a vital role in public health.

The Contraceptives Market size was valued at USD 1.30 billion in 2023 and is expected to reach at USD 6.10 billion by 2031 with a growing CAGR of 21.20% over the forecast period of 2024-2031.

Future Scope

The future of the contraceptives market is expected to focus on innovation in both hormonal and non-hormonal contraceptive methods, aiming to reduce side effects and enhance user convenience. Emerging trends indicate a growing interest in male contraceptive options, such as contraceptive gels and pills, which could reshape the market by expanding responsibility beyond female users. In addition, the rise of digital health platforms may facilitate access to contraceptive counseling and prescriptions, improving accessibility in underserved regions and promoting greater autonomy in family planning decisions.

Trends

Notable trends in the contraceptives market include the development of long-acting reversible contraceptives (LARCs), such as implants and IUDs, which offer extended protection with minimal user intervention. The popularity of over-the-counter contraceptives, particularly in regions with limited access to healthcare providers, is also rising. Furthermore, innovations in contraceptive technology are leading to low-dose hormonal options, which reduce the risk of side effects. Digital health is also impacting this market by connecting users with remote consultations and telemedicine services, making it easier to access information and care.

Applications

Contraceptives are widely used in healthcare settings, family planning centers, and increasingly through online pharmacies. They play a crucial role in public health initiatives aimed at controlling population growth and reducing maternal and infant mortality. Contraceptives are also used by individuals to manage health conditions such as polycystic ovary syndrome (PCOS) and menstrual irregularities. With a variety of contraceptive options available, users can choose the method that best suits their lifestyle, health needs, and family planning goals.

Key Points

Vital for family planning and reproductive health management.

Growing demand for innovation in contraceptive methods, including male contraceptives.

Trends include long-acting contraceptives, low-dose hormonal options, and telemedicine access.

Applications in healthcare, family planning centers, and online pharmacies.

Digital health platforms enhancing access to contraceptives and reproductive counseling.

Conclusion

The contraceptives market is evolving to meet the diverse needs of individuals seeking control over their reproductive health. As advancements continue, the market is expected to offer more personalized and innovative options, catering to a broad user base and supporting gender equality in family planning. With increased awareness, government support, and digital health integration, the contraceptives market is poised for growth, empowering individuals worldwide to make informed decisions about their reproductive health.

Read More Details: https://www.snsinsider.com/reports/contraceptives-market-2791 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND) 

[tbrcresearchreport]

The Business Research Company offers contraceptives market research report 2023 with industry size, share, segments and market growth

[roseaa11]

Data Bridge Market Research analyses a growth rate in the hormonal contraceptive market in the forecast period 2023-2030. The expected CAGR of the hormonal contraceptive market tends to be around 4.60% in the mentioned forecast period. The market was valued at USD 16.6 billion in 2022 and would grow to USD 23.79 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

[marketspace360]

Hormonal Contraceptives Market | Manufacturers, Regions, Type and Application, Forecast by 2029

[market-insider]

U.S. Contraceptive Market Showing Rapid Growth In Subdermal Implants Segments

The U.S. contraceptive market size is expected to reach USD 12.0 billion by 2030 registering a CAGR of 4.70%, according to a new report by Grand View Research, Inc. Improving access and awareness regarding Long-Acting Reversible Contraceptives (LARCs) and the effectiveness and convenience of using these products are expected to drive the growth of the industry. The Guttmacher Institute reported that 60% of women belonging to the reproductive age use contraception in the U.S. Use of hormonal contraceptives other than the birth control pill has significantly increased in married women.

Gain deeper insights on the market and receive your free copy with TOC now @: U.S. Contraceptive Market Report

The increasing availability of contraceptives in the U.S. has improved several aspects of society such as education, career opportunities, and poverty for women. Access to modern methods of contraception has significantly improved career opportunities and allowed women to earn wages at par with men. Moreover, it has also reduced the number of women living in poverty due to unintended pregnancies and the high costs associated with raising a child. The legalization of family planning in the majority of the states has reduced the economic burden for the next generation as there has been a substantial reduction in the number of citizens living in poverty as adults.

The onset of the COVID-19 pandemic has showcased a negative impact on the market partially offsetting the initiatives by manufacturers. Short-term contraceptives such as birth control pills and condoms require re-prescription filling and frequent purchase, which may increase the risk of exposure to the virus. Thus, usage of these products has been limited during the pandemic. Moreover, the availability and distribution of contraceptives at public healthcare centers have been impacted in the U.S. Unemployment and loss of insurance that covers expenses of contraceptives in the U.S. are also anticipated to limit usage during the COVID-19 pandemic.

[janetushar1]

Contraceptive Drugs Market to Hit $18.94 Billion by 2032

The global Contraceptive Drugs Market was valued at USD 6.31 Billion in 2024 and it is estimated to garner USD 18.94 Billion by 2032 with a registered CAGR of 5.2% during the forecast period 2024 to 2032.

Are you looking for the Contraceptive Drugs Market Research Report? You are at the right place. If you desire to find out more data about the report or want customization, Contact us. If you want any unique requirements, please allow us to customize and we will offer you the report as you want.

The global Contraceptive Drugs Market can be segmented on the basis of product type, Applications, distribution channel, market value, volume, and region [North America, Europe, Asia Pacific, Latin America, Middle East, and Africa]. The Contraceptive Drugs Industry 2024 report provides a comprehensive overview of critical elements of the industry including drivers, restraints, and management scenarios.

Download Sample PDF: @ https://www.vantagemarketresearch.com/contraceptive-drugs-market-1674/request-sample

Top Players

Agile Therapeutics, Allergan PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd. and others.

Trending 2024: Contraceptive Drugs Market Report Highlights:

A comprehensive assessment of the parent Industry

Development of key aspects of the business

A study of industry-wide market segments

Evaluation of market value and volume in past, present, and future years

Evaluation of market share

Tactical approaches of market leaders

Innovative strategies that help companies to improve their position in the market

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/contraceptive-drugs-market-1674/0

Analysis Of The Top Companies, Product Types, and Applications In The Market Report:

This report provides sales, revenue growth rate, and verified information about the major players. Also includes a regional analysis and a labor cost analysis, tables, and figures. It also highlights characteristics such as technological growth. The product type segment is expected to continue to maintain its leading position in the future and capture a significant market share based on sales. This report provides analysis, discussion, forecast, and debate on key industry trends, market share estimates, Industry size, and other information. This report also discusses drivers, risks, and opportunities.

Global Contraceptive Drugs Market report contains detailed data and analysis on the Contraceptive Drugs Market drivers, restraints, and opportunities. Experts with market and industry knowledge as well as research experience from regional experts validate the report. The Contraceptive Drugs Market report provides forecast, historical and current revenue for each industry, region, and end-user segment.

Regions Included

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

Global Contraceptive Drugs Market report data will help you make more informed decisions. For example, in relation to prices, distribution channels are means of marketing or identifying opportunities to introduce a new product or service. These results will also help you make more informed decisions about your existing operations and activities.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/contraceptive-drugs-market-1674

You Can Use The Contraceptive Drugs Market Report To Answer The Following Questions:

What are the growth prospects of the Contraceptive Drugs Market business?

Who are the key manufacturers in the Contraceptive Drugs Market space?

What Forecast Period for Global Contraceptive Drugs Industry Report?

What are the main segments of the global Contraceptive Drugs Market?

What are the key metrics like opportunities and market drivers?

The Contraceptive Drugs Market Insights

Product Development/Innovation: Detailed Information On Upcoming Technologies, R&D Activities, And Product Launches In The Market.

Competitive Assessment: In-Depth Assessment Of Market Strategies, Geographic And Business Segments Of Key Market Players.

Market Development: Comprehensive Information On Emerging Markets. This Report Analyzes The Market For Different Segments In Different Regions.

Market Diversification: Comprehensive Information On New Products, Untapped Regions, Latest Developments, And Investments In The Contraceptive Drugs Market.

Check Out More Reports

Global Proppants Market:  Report Forecast by 2032

Global Water Treatment Chemicals Market: Report Forecast by 2032

Global Food Coating Market: Report Forecast by 2032

Global Manual Call Point Market: Report Forecast by 2032

Global 3D Printing Ceramic Market: Report Forecast by 2032

[insightfulblogz]

Hormonal Contraceptives Market Product Development Strategies by Prominent Players, 2032

Hormonal contraceptives are a cornerstone of modern reproductive health, offering women effective and flexible methods to prevent pregnancy while managing menstrual-related issues. These medications work by altering the hormonal balance in the body, primarily through synthetic estrogen and progesterone, to inhibit ovulation and fertilization. Available in various forms, including oral pills, injections, patches, and intrauterine devices (IUDs), hormonal contraceptives empower women with greater control over their reproductive health, contributing to improved well-being and life planning.

The Hormonal Contraceptives Market size was valued at USD 17.58 Billion in 2023 and is expected to reach USD 25.39 Billion By 2031 with a growing CAGR of 4.70% over the forecast period of 2024-2031.

Future Scope

The future of hormonal contraceptives lies in developing more targeted and personalized solutions with fewer side effects. Researchers are exploring non-hormonal methods, long-acting reversible contraceptives, and options for male contraception to expand choices. Advances in biotechnology are paving the way for smart delivery systems, such as implants with controlled-release mechanisms and contraceptives integrated with digital health technologies to monitor and optimize use. These innovations aim to enhance efficacy, convenience, and accessibility.

Emerging Trends

A significant trend in hormonal contraceptives is the focus on eco-friendly formulations to reduce environmental impact. Biodegradable delivery systems and hormone levels that minimize ecological contamination are gaining attention. Additionally, telemedicine platforms are transforming access to contraceptives, enabling remote consultations and home delivery. Efforts to combine hormonal contraceptives with other health benefits, such as acne treatment or menopause management, are also shaping product development.

Applications

Hormonal contraceptives are primarily used for birth control, providing effective pregnancy prevention. They are also widely utilized in managing hormonal imbalances, regulating menstrual cycles, reducing menstrual cramps, and treating conditions such as polycystic ovary syndrome (PCOS) and endometriosis. Their versatility extends to skin health, where they address acne and related issues. As family planning tools, they contribute significantly to public health and women’s empowerment globally.

Key Points

Hormonal contraceptives include oral pills, patches, injections, and IUDs.

They prevent pregnancy while managing menstrual and hormonal issues.

Future innovations focus on smart delivery systems and male contraceptives.

Trends emphasize eco-friendly formulations and telemedicine access.

Applications extend to acne treatment and hormonal disorder management.

Conclusion

Hormonal contraceptives are a critical component of modern healthcare, offering a combination of efficacy, convenience, and versatility. As research drives innovation and access improves through digital platforms, the future of contraception promises enhanced choices and greater inclusivity. With ongoing advancements, hormonal contraceptives will continue to play a pivotal role in empowering reproductive health worldwide.

Read More Details: https://www.snsinsider.com/reports/hormonal-contraceptives-market-3063 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND) 

[stevenwilliam12]

Gonorrhea Market Forecast and Insights: Trends and Treatment Advances to 2032

Gonorrhea, a prevalent sexually transmitted infection (STI) caused by Neisseria gonorrhoeae, remains a critical public health issue worldwide. If left untreated, gonorrhea can lead to severe health complications, including infertility, pelvic inflammatory disease, and an increased risk of HIV. The rising prevalence of antibiotic-resistant strains of gonorrhea has heightened the urgency for effective treatments and spurred the development of new therapeutic options.

Gonorrhea Market Insights

The gonorrhea treatment market is primarily driven by the increasing incidence of infection and heightened awareness regarding STI prevention and management. While traditional antibiotics like ceftriaxone and azithromycin are commonly used to treat gonorrhea, the emergence of antibiotic resistance is compromising their efficacy. This growing resistance has led to significant research and development (R&D) efforts aimed at creating novel treatment strategies, including dual therapy regimens and new classes of antibiotics. Additionally, the rising demand for rapid diagnostic tests to guide appropriate treatment is contributing to market growth, especially in areas with high infection rates.

The gonorrhea treatment market is expected to expand significantly, particularly in North America and Europe, where robust healthcare infrastructures facilitate early diagnosis and intervention. In contrast, emerging markets in Asia-Pacific and Africa are anticipated to experience growth due to increasing STI awareness and improved access to healthcare services.

Key Gonorrhea Companies in the Market

Leading companies in the gonorrhea treatment market include Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics, Alopexx Pharmaceuticals, Nobelex Biotech, Summit Therapeutics, TherapyX, Achilles Vaccines, Recce Pharmaceuticals, VenatoRx Pharmaceuticals, and others, all contributing to the development of innovative treatment options.

Gonorrhea Epidemiology

According to the World Health Organization (WHO), gonorrhea affects millions of individuals globally, with over 80 million new cases reported annually. Young adults, particularly those aged 15-24, account for a substantial proportion of these new infections. Gonorrhea is more prevalent in urban areas, with higher rates observed in marginalized communities and among populations with limited access to healthcare. Furthermore, the increasing incidence of antibiotic-resistant gonorrhea strains poses a significant challenge to effective treatment strategies.

Gonorrhea Market Forecast to 2032

The gonorrhea market size is projected to grow at a compound annual growth rate (CAGR) of approximately 4-5% through 2032. This growth is driven by increased investments in R&D and the introduction of new therapies designed to target resistant strains. The development of combination therapies, novel antibiotics, and improved diagnostic tools will play a pivotal role in shaping the market landscape. Governments and healthcare organizations are also intensifying efforts to combat gonorrhea through awareness campaigns and funding initiatives for the development of new treatments.

ConclusionIn conclusion, the gonorrhea market outlook through 2032 shows promising growth potential, fueled by the pressing need for effective treatment options in response to rising infection rates, antibiotic resistance, and expanded STI prevention initiatives on a global scale.

Latest Reports

Contraceptive Devices Market | Crohns Disease Cd Market | Cutaneous T-cell Lymphoma Market | Diabetic Neuropathy Market | Ehlers-danlos Syndrome Market | Encephalitis Market | Epidermolysis Bullosa Market | Familial Amyloid Polyneuropathy Market | Healthcare Competitive Benchmarking | Hepatic Encephalopathy Epidemiology Forecast | Hepatitis B Virus Market | Hepatitis D Market | Hereditary Spastic Paraplegias Market | Hpv-induced Cancers Market | Human Papillomavirus Positive Cancer Market | Hyperkalemia Market | Nontuberculous Mycobacteria Infection Market | Post-bariatric Hypoglycemia Market | Postsurgical Pain Market | Primary Progressive Multiple Sclerosis Ppms Market | Surgical Stapling Devices Market | Vascular Access Devices Market | Vascular Dementia Market | Wound Closure Devices Market | Xerostomia Market

[harshnews]

Menstrual Cramps Treatment Market Size, Share, Trends, Growth and Competitive Analysis

"Global Menstrual Cramps Treatment Market – Industry Trends and Forecast to 2030

Global Menstrual Cramps Treatment Market, By Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment Type (Medication, Therapy, Surgery, Others), Diagnosis (Ultrasound, Laparoscopy, CT scan, magnetic resonance imaging (MRI), Others), Mode of Prescription (Over the Counter, Prescription), Route of Administration (Oral, Parenteral, Implants, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.

Access Full 350 Pages PDF Report @

**Segments**

- **Treatment Type** - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - Hormonal Contraceptives - Alternative Therapies

- **Distribution Channel** - Retail Pharmacies - Online Pharmacies - Others

- **Region** - North America - Europe - Asia-Pacific - Latin America - Middle East and Africa

The menstrual cramps treatment market can be segmented based on treatment type, distribution channel, and region. In terms of treatment type, the market is divided into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Hormonal Contraceptives, and Alternative Therapies. NSAIDs are commonly used to relieve menstrual cramp pain by reducing inflammation. Hormonal contraceptives like birth control pills can help regulate menstrual cycles and alleviate cramps. Alternative therapies such as acupuncture, yoga, and herbal remedies are also increasingly being sought after for managing menstrual cramps. Regarding distribution channels, the market is categorized into retail pharmacies, online pharmacies, and others. Retail pharmacies remain a crucial channel for consumers to access over-the-counter and prescription menstrual cramp treatments, while the online pharmacies segment is witnessing significant growth due to the convenience and privacy they offer to consumers. Geographically, the market is analyzed across regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, each presenting unique market dynamics and opportunities for menstrual cramps treatment products.

**Market Players**

- **Pfizer Inc.** - **Bayer AG** - **Sanofi** - **Johnson & Johnson Services, Inc.** - **Merck & Co., Inc.** - **Novartis AG** - **Abbott** - **Reckitt Benckiser Group plc** - **GlaxoSmithKline plc** - **Mylan N.V.**

Key players in the menstrual cramps treatment market include pharmaceutical giants such asThe menstrual cramps treatment market is highly competitive with several key players dominating the industry. Pfizer Inc., known for its wide range of pharmaceutical products, offers NSAIDs and hormonal contraceptives targeting menstrual cramp relief. Bayer AG is another major player in the market with a focus on women's health, providing hormonal contraceptives and alternative therapies for menstrual cramp management. Sanofi, a global pharmaceutical company, also has a presence in the market with its diverse portfolio of treatment options for menstrual cramps. Johnson & Johnson Services, Inc., a well-known healthcare company, offers over-the-counter medications and medical devices for menstrual cramp relief. Merck & Co., Inc. is another significant player in the market, known for its research and development in women's health therapeutics.

Novartis AG, a Swiss multinational pharmaceutical company, has a presence in the menstrual cramps treatment market with its innovative products and research initiatives. Abbott, a global healthcare company, also participates in the market with its range of pharmaceuticals and healthcare products aimed at women's health. Reckitt Benckiser Group plc, a British multinational consumer goods company, offers over-the-counter remedies and alternative therapies for menstrual cramp management. GlaxoSmithKline plc, a leading healthcare company, provides a variety of pharmaceutical products targeting menstrual cramps. Mylan N.V., a global pharmaceutical company, also competes in the market with its portfolio of affordable generic medications for menstrual cramp treatment.

These key players in the menstrual cramps treatment market are constantly innovating and investing in research and development to introduce new and improved treatment options for consumers. They also focus on strategic partnerships and acquisitions to expand their market presence and reach a wider consumer base. Market players are increasingly focusing on product differentiation, pricing strategies, and marketing initiatives to stand out in the competitive landscape and capture a larger share of the market.

Factors such as increasing awareness about menstrual health, growing prevalence of menstrual disorders, and rising demand for alternative therapies are driving the**Segments**

- **Global Menstrual Cramps Treatment Market, By Type** - Primary Dysmenorrhea - Secondary Dysmenorrhea

- **Treatment Type** - Medication - Therapy - Surgery - Others

- **Diagnosis** - Ultrasound - Laparoscopy - CT scan - Magnetic Resonance Imaging (MRI) - Others

- **Mode of Prescription** - Over the Counter - Prescription

- **Route of Administration** - Oral - Parenteral - Implants - Others

- **End-Users** - Hospitals - Specialty Clinics - Homecare - Others

- **Distribution Channel** - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy - Others

The global menstrual cramps treatment market exhibits various segments crucial for understanding the market landscape and catering to the diverse needs of consumers seeking relief from menstrual cramps. The differentiation between primary and secondary dysmenorrhea helps in tailoring treatments specific to the underlying causes of menstrual pain. Treatment types such as medication, therapy, surgery, and alternative therapies offer a spectrum of options for managing menstrual cramps effectively. Diagnostics tools like ultrasound, laparoscopy, CT scans, and MRI play a pivotal role in identifying underlying conditions contributing to menstrual pain, enabling healthcare providers to suggest targeted treatment approaches. The mode

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers and Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Core Objective of Menstrual Cramps Treatment Market:

Every firm in the Menstrual Cramps Treatment Market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.

Size of the Menstrual Cramps Treatment Market and growth rate factors.

Important changes in the future Menstrual Cramps Treatment Market.

Top worldwide competitors of the Market.

Scope and product outlook of Menstrual Cramps Treatment Market.

Developing regions with potential growth in the future.

Tough Challenges and risk faced in Market.

Global Menstrual Cramps Treatment top manufacturers profile and sales statistics.

Browse Trending Reports:

Meat Poultry And Seafood Processing Equipment Market Hemiballismus Treatment Market Fluid And Lubricant Market Virtual Infrastructure Manager Market Water Flosser Market Water Saving Shower Heads Market Galactoligosaccharides Market Rocky Mountain Spotted Fever Treatment Market Overhead Conveyor Market Olliers Disease Market Functional Bowel Disorder Agents Market Bio Based Leather Market Melanoma Cancer Diagnostics Market Intracranial Hematoma Drug Market Glucosinolates Market Autorefractor Keratometer Device Market Feed Mycotoxin Modifiers Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[amrutatbrc1]

Contraceptive Devices Market : Technology Advancements, Industry Insights, Trends And Forecast 2033

The contraceptive devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Contraceptive Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -

The contraceptive devices market size has grown strongly in recent years. It will grow from $12.05 billion in 2023 to $12.8 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to growing awareness about the importance of family planning and contraceptive methods, government initiatives, increasing global population, greater focus on women's health and empowerment, improving access to healthcare facilities.

The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $16.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing awareness of sexual health and STD prevention, economic benefits of controlling family size, growing cultural acceptance of contraceptive use, high proportion of young population in reproductive age, influence of social media on spreading awareness. Major trends in the forecast period include innovations in contraceptive technologies, educational campaigns by NGOs and health organizations advancements in pharmaceutical formulations, availability of a wide range of contraceptive products, investment in research and development for new contraceptive methods.

Order your report now for swift delivery @

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers -

The growing prevalence of sexually transmitted diseases is expected to propel the growth of the contraceptive device market going forward. Sexually transmitted diseases (STDs) are infections transmitted primarily through sexual contact, affecting various body parts and potentially leading to a range of symptoms and health complications. Sexually transmitted diseases are rising due to increased sexual activity, a lack of proper protection, insufficient sexual health education, and challenges in access to healthcare and testing. Contraceptive devices, especially condoms, are required for sexually transmitted diseases because they provide a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For instance, in July 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, in England, there were 401,800 new STI diagnoses in 2023, marking a 4.7% increase from the 383,789 cases reported in 2022. Diagnoses of gonorrhoea rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023. Meanwhile, infectious syphilis diagnoses saw a 9.4% increase, rising from 8,693 in 2022 to 9,513 in 2023. Therefore, the growing prevalence of sexually transmitted diseases is driving the growth of the contraceptive device market.

Market Trends -

Major companies operating in the contraceptive device market are developing innovative products, such as contraceptive vaginal rings, to provide a convenient, low-maintenance method of birth control with a once-a-month insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina that prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, launched the EnilloRing. The EnilloRing, developed by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is designed for long-term use, remaining in place for three weeks. After this period, it is followed by a one-week ring-free interval to effectively prevent pregnancy.

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Get an inside scoop of the contraceptive devices market, Request now for Sample Report @

Regional Insights -

North America was the largest region in the contraceptive devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies -

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Table of Contents

1. Executive Summary

2. Contraceptive Devices Market Report Structure

3. Contraceptive Devices Market Trends And Strategies

4. Contraceptive Devices Market – Macro Economic Scenario

5. Contraceptive Devices Market Size And Growth

…..

27. Contraceptive Devices Market Competitor Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[haggishlyhagging]

“Although the oppression of women is universal, feminist consciousness is not. While I am not sure that I could demonstrate the necessity of its appearance in this time and place and not in another, I believe it is possible to identify two features of current social reality which, if not sufficient, are at least necessary conditions for the emergence of feminist consciousness. These features constitute, in addition, much of the content of this consciousness. I refer, first, to the existence of what Marxists call ‘contradictions’ in our society and, second, to the presence, due to these same contradictions, of concrete circumstances which would permit a significant alteration in the status of women.

In Marxist theory, the stage is set for social change when existing forms of social interaction—property relations as well as values, attitudes, and beliefs—come into conflict with new social relations which are generated by changes in the mode of production:

At a certain stage of their development, the material forces of production in society come in conflict with the existing relations of production or—what is but a legal expression for the same thing—with the property relations within which they had been at work before. From forms of development of the forces of production these relations turn into their fetters. Then comes the period of social revolution.

Social conflict regularly takes an ideological form, so much so that conflicts which are fundamentally economic in origin may appear to be struggles between ideas, as, for instance, between competing conceptions of the nature of legitimate political authority or of woman's proper sphere. To date, no one has offered a comprehensive analysis of those changes in the socioeconomic stricture of contemporary American society which have made possible the emergence of feminist consciousness. This task is made doubly difficult by the fact that these changes constitute no completed process, no convenient object for dispassionate historical investigation, but are part of the fluid set of circumstances in which each of us must find our way from one day to another and whose ultimate direction is as yet unclear. In spite of this, several features of current social reality cannot escape notice.

First, if we add to the Marxist notion of ‘modes of production’ the idea of ‘modes of (biological) reproduction,’ then it is evident that the development of cheap and efficient types of contraception has been instrumental in changing both the concrete choices women are able to make and the prevailing conceptions about woman's function and destiny. Second, the rapid growth of service industries has had much to do with the steady rise in the percentage of women in the work force, since the post-World War II low in the early fifties. While poor women and women of color have often had to work for wages, middle-class women were largely restricted to the roles of wife, mother, and home maker; this restriction, together with the rationales that justify it, is clearly out of phase with the entry of millions of such women into the market economy. The growth and spread of a technology to ease the burden of housekeeping, a technology which is itself the result of a need on the part of late capitalism for ‘innovations’ in production, serves further to undermine traditional conceptions about woman's place. During part of the period of the most rapid rise in the percentage of women in the work force, to cite still another ‘contradiction,’ there appeared an anomalous and particularly virulent form of the ‘feminine mystique,’ which, together with its companion, the ideal of ‘togetherness,’ had the effect, among other things, of insuring that the family would remain an efficient vehicle of consumption. What triggered feminist consciousness most immediately, no doubt, were the civil rights movement and the peace and student movements of the sixties; while they had other aims as well, the later movements may also be read as expressions of protest against the growing bureaucratization, depersonalization, and inhumanity of late capitalist society. Women often found themselves forced to take subordinate positions within these movements; it did not take long for them to see the contradiction between the oppression these movements were fighting in the larger society and their own continuing oppression in the life of these movements themselves.”

-Sandra Lee Bartky, Femininity and Domination: Studies in the Phenomenology of Oppression